Research & Development



  “估計只有董仲舒自己。”   他接到這些消息的時間遠比留在長安的甦稚她們早,知道之後,不論是他還是曹襄都閉口不言,李敢更是只能被動的防御不能反擊。久久精品视频在线看4   你徹底放棄永安縣,我舅舅會一口吞下,然後繼續謀算平陽縣。青娱乐官网极品盛宴   曹襄怒道︰“你一定要借陛下的名頭為你史家揚名是不是?”   “慢慢來……”色爱区区域综合网   雲瑯跟曹襄的表章都是司馬遷寫的,他們審閱之後發現司馬遷寫的很好,就交給了丞相趙周,再由丞相府將表章呈遞給皇帝,好讓皇帝開心一下。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo